Coimbra Susana, Reis Flávio, Ferreira Cátia, Nunes Sara, Viana Sofia, Catarino Alice, Rocha-Pereira Petronila, Belo Luís, Monteiro Luís, Catarino Cristina, Santos-Silva Alice
UCIBIO\REQUIMTE, Porto; CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra-Paredes, Portugal.
iCBR, Instituto de Investigação Clínica e Biomédica de Coimbra, Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal.
Clin Biochem. 2019 Jan;63:46-53. doi: 10.1016/j.clinbiochem.2018.10.007. Epub 2018 Oct 17.
Weight loss achieved by laparoscopic adjustable gastric banding (LAGB) induces an increase in high-density lipoprotein cholesterol (HDLc) but a small effect on low-density lipoprotein (LDL), although changes in their quality (size and composition) are uncertain. Our aim was to study the impact of weight loss, achieved 13-months after LAGB, on inflammation and dyslipidemia, focusing on HDL and LDL subfractions, and oxidized LDL (oxLDL).
DESIGN & METHODS: We evaluated standard lipid profile, HDL and LDL subfractions, oxLDL, interleukin (IL)-6 and C-reactive protein (CRP), in twenty obese patients, before (T0) and 13-months after LAGB (T1), and in seventeen healthy controls.
At T1, patients showed lower body weight (12% median weight loss) and anthropometric indices; reduction in TG, atherogenic indices, oxLDL, oxLDL/LDL ratio, CRP and IL-6, and enhancement in HDLc; an increase in large HDL and intermediate HDL subfractions, and a decrease in small HDL subfraction; LDL subfractions were not modified. Percentual change (%Δ) of oxLDL, from T0 to T1, correlated significantly and positively with %Δ of small HDL subfraction and with %Δ of body mass index.
Weight loss induced atheroprotective changes on inflammation, and lipid profile, enhancing larger HDL, the more atheroprotective subfraction, reducing the less protective subclass, small HDL, and reducing oxLDL and oxLDL/LDL ratio. Quality of lipoproteins appears useful cardiovascular risk biomarkers, deserving further studies.
腹腔镜可调节胃束带术(LAGB)实现的体重减轻会导致高密度脂蛋白胆固醇(HDLc)升高,但对低密度脂蛋白(LDL)的影响较小,尽管其质量(大小和组成)的变化尚不确定。我们的目的是研究LAGB术后13个月实现的体重减轻对炎症和血脂异常的影响,重点关注HDL和LDL亚组分以及氧化LDL(oxLDL)。
我们评估了20名肥胖患者在LAGB术前(T0)和术后13个月(T1)以及17名健康对照者的标准血脂谱、HDL和LDL亚组分、oxLDL、白细胞介素(IL)-6和C反应蛋白(CRP)。
在T1时,患者体重降低(体重中位数减轻12%),人体测量指标改善;甘油三酯、致动脉粥样硬化指数、oxLDL、oxLDL/LDL比值、CRP和IL-6降低,HDLc升高;大HDL和中间HDL亚组分增加,小HDL亚组分减少;LDL亚组分未改变。从T0到T1,oxLDL的百分比变化(%Δ)与小HDL亚组分的%Δ以及体重指数的%Δ显著正相关。
体重减轻对炎症和血脂谱产生了抗动脉粥样硬化的变化,增加了更具抗动脉粥样硬化作用的大HDL亚组分,减少了保护性较差的小HDL亚类,降低了oxLDL和oxLDL/LDL比值。脂蛋白质量似乎是有用的心血管风险生物标志物,值得进一步研究。